Skip to main content
TipRanks
Go Ultimate75% OFF

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Financial Statements

0 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Financial Overview

Shanghai Haohai Biological Technology Co., Ltd. Class H's market cap is currently ¥7.28B. The company's EPS TTM is ¥0.44; its P/E ratio is 59.98; and it has a dividend yield of 6.23%. Shanghai Haohai Biological Technology Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.45B¥ 2.68B¥ 2.63B¥ 2.10B¥ 1.75B
Gross Profit¥ 1.69B¥ 1.87B¥ 1.85B¥ 1.45B¥ 1.26B
Operating Income¥ 221.63M¥ 347.93M¥ 438.38M¥ 155.81M¥ 176.03M
EBITDA¥ 445.99M¥ 577.25M¥ 713.41M¥ 447.55M¥ 550.45M
Net Income¥ 244.51M¥ 420.45M¥ 416.12M¥ 180.47M¥ 352.23M
Balance Sheet
Cash & Short-Term Investments¥ 2.52B¥ 2.76B¥ 2.75B¥ 2.56B¥ 2.91B
Total Assets¥ 6.72B¥ 7.12B¥ 7.11B¥ 6.89B¥ 6.95B
Total Debt¥ 398.67M¥ 448.43M¥ 407.95M¥ 118.26M¥ 105.51M
Net Debt¥ -2.05B¥ -2.18B¥ -2.33B¥ -2.42B¥ -2.80B
Total Liabilities¥ 1.12B¥ 1.20B¥ 1.09B¥ 990.02M¥ 890.07M
Stockholders' Equity¥ 5.42B¥ 5.58B¥ 5.65B¥ 5.51B¥ 5.71B
Cash Flow
Free Cash Flow¥ 446.40M¥ 283.08M¥ 367.22M¥ -85.85M¥ 70.19M
Operating Cash Flow¥ 628.50M¥ 648.57M¥ 634.45M¥ 231.30M¥ 342.29M
Investing Cash Flow¥ -10.81M¥ 282.28M¥ -376.65M¥ -681.82M¥ -148.09M
Financing Cash Flow¥ -509.70M¥ -390.35M¥ -257.73M¥ -288.35M¥ -231.25M

Currency in CNY

Shanghai Haohai Biological Technology Co., Ltd. Class H Earnings and Revenue History

01B2B3B0 %10 %20 %30 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Shanghai Haohai Biological Technology Co., Ltd. Class H Liabilities to Assets

02.5B5B7.5B5 %10 %15 %20 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Shanghai Haohai Biological Technology Co., Ltd. Class H Cash Flow

-1.5B-1B-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing

Shanghai Haohai Biological Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

-0.5-0.200.30.50.8Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss